186 related articles for article (PubMed ID: 25808870)
1. CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.
Hu S; Danilov AV; Godek K; Orr B; Tafe LJ; Rodriguez-Canales J; Behrens C; Mino B; Moran CA; Memoli VA; Mustachio LM; Galimberti F; Ravi S; DeCastro A; Lu Y; Sekula D; Andrew AS; Wistuba II; Freemantle S; Compton DA; Dmitrovsky E
Cancer Res; 2015 May; 75(10):2029-38. PubMed ID: 25808870
[TBL] [Abstract][Full Text] [Related]
2. Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown.
Hu S; Lu Y; Orr B; Godek K; Mustachio LM; Kawakami M; Sekula D; Compton DA; Freemantle S; Dmitrovsky E
Mol Cancer Ther; 2015 Nov; 14(11):2576-85. PubMed ID: 26304236
[TBL] [Abstract][Full Text] [Related]
3. Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2.
Danilov AV; Hu S; Orr B; Godek K; Mustachio LM; Sekula D; Liu X; Kawakami M; Johnson FM; Compton DA; Freemantle SJ; Dmitrovsky E
Mol Cancer Ther; 2016 Nov; 15(11):2758-2766. PubMed ID: 27550941
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.
Kawakami M; Mustachio LM; Rodriguez-Canales J; Mino B; Roszik J; Tong P; Wang J; Lee JJ; Myung JH; Heymach JV; Johnson FM; Hong S; Zheng L; Hu S; Villalobos PA; Behrens C; Wistuba I; Freemantle S; Liu X; Dmitrovsky E
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28376145
[TBL] [Abstract][Full Text] [Related]
5. Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers.
Kawakami M; Mustachio LM; Liu X; Dmitrovsky E
Mol Cancer Ther; 2018 Apr; 17(4):724-731. PubMed ID: 29559545
[TBL] [Abstract][Full Text] [Related]
6. A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers.
Kawakami M; Mustachio LM; Chen Y; Chen Z; Liu X; Wei CH; Roszik J; Kittai AS; Danilov AV; Zhang X; Fang B; Wang J; Heymach JV; Tyutyunyk-Massey L; Freemantle SJ; Kurie JM; Liu X; Dmitrovsky E
Mol Cancer Ther; 2021 Mar; 20(3):477-489. PubMed ID: 33277443
[TBL] [Abstract][Full Text] [Related]
7. Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe.
Galimberti F; Thompson SL; Liu X; Li H; Memoli V; Green SR; DiRenzo J; Greninger P; Sharma SV; Settleman J; Compton DA; Dmitrovsky E
Clin Cancer Res; 2010 Jan; 16(1):109-20. PubMed ID: 20028770
[TBL] [Abstract][Full Text] [Related]
8. TRIGGERING ANAPHASE CATASTROPHE TO COMBAT ANEUPLOID CANCERS.
Dmitrovsky E; Kawakami M; Liu XI; Freemantle SJ; Kurie JM
Trans Am Clin Climatol Assoc; 2020; 131():82-94. PubMed ID: 32675848
[TBL] [Abstract][Full Text] [Related]
9. CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells.
Chen Z; Liu X; Kawakami M; Liu X; Baker A; Bhatawadekar A; Tyutyunyk-Massey L; Narayan K; Dmitrovsky E
Cancer Biol Ther; 2023 Dec; 24(1):2279241. PubMed ID: 38031910
[TBL] [Abstract][Full Text] [Related]
10. A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation.
Sharma SS; Ma L; Bagui TK; Forinash KD; Pledger WJ
Oncogene; 2012 Aug; 31(35):3989-98. PubMed ID: 22158041
[TBL] [Abstract][Full Text] [Related]
11. Anaphase catastrophe is a target for cancer therapy.
Galimberti F; Thompson SL; Ravi S; Compton DA; Dmitrovsky E
Clin Cancer Res; 2011 Mar; 17(6):1218-22. PubMed ID: 21288923
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
13. Synergy of WEE1 and mTOR Inhibition in Mutant
Hai J; Liu S; Bufe L; Do K; Chen T; Wang X; Ng C; Li S; Tsao MS; Shapiro GI; Wong KK
Clin Cancer Res; 2017 Nov; 23(22):6993-7005. PubMed ID: 28821559
[No Abstract] [Full Text] [Related]
14. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
15. Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK.
Wang J; Hu K; Guo J; Cheng F; Lv J; Jiang W; Lu W; Liu J; Pang X; Liu M
Nat Commun; 2016 May; 7():11363. PubMed ID: 27193833
[TBL] [Abstract][Full Text] [Related]
16. Cep97 and CP110 suppress a cilia assembly program.
Spektor A; Tsang WY; Khoo D; Dynlacht BD
Cell; 2007 Aug; 130(4):678-90. PubMed ID: 17719545
[TBL] [Abstract][Full Text] [Related]
17. Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
Balbin OA; Prensner JR; Sahu A; Yocum A; Shankar S; Malik R; Fermin D; Dhanasekaran SM; Chandler B; Thomas D; Beer DG; Cao X; Nesvizhskii AI; Chinnaiyan AM
Nat Commun; 2013; 4():2617. PubMed ID: 24135919
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.
Herz C; Schlürmann F; Batarello D; Fichter CD; Schöpflin A; Münch C; Hauschke D; Werner M; Lassmann S
Mol Carcinog; 2012 Sep; 51(9):696-710. PubMed ID: 21739483
[TBL] [Abstract][Full Text] [Related]
19. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
[TBL] [Abstract][Full Text] [Related]
20. CP110 suppresses primary cilia formation through its interaction with CEP290, a protein deficient in human ciliary disease.
Tsang WY; Bossard C; Khanna H; Peränen J; Swaroop A; Malhotra V; Dynlacht BD
Dev Cell; 2008 Aug; 15(2):187-97. PubMed ID: 18694559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
